Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05143255 · ClinicalTrials.gov registry record · NA

Developing a Communication Intervention for People With Memory Challenges and Their Care Partners

A NA study of Alzheimer Disease and Dementia, sponsored by Weill Medical College of Cornell University.

Active
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT05143255 is a NA study of Alzheimer Disease and Dementia that is active but no longer recruiting, run by Weill Medical College of Cornell University. The registered enrollment target is 90 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05143255, a NA study of Alzheimer Disease and Dementia, is active but no longer recruiting, sponsored by Weill Medical College of Cornell University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The proposed research is consistent with broader public health goals focused on improving communication regarding end-of-life care and the Centers for Medicare and Medicaid Services' (CMS) call for increased patient engagement in advance care planning (ACP) as part of standard care. The proposed study will address this public health issue by developing a communication-based intervention designed to improve Alzheimer's Disease and Related Dementias (ADRD) patients' and care partners' engagement in ACP, distress and care partner burden, and completion of advance directives and receipt of goal-concordant care at the end-of-life. Therefore, this study is aligned with the National Institute on Aging's long-term goal to improve the quality of care for ADRD patients and CMS's goal to increase engagement in ACP.

Interventions

  • BEHAVIORAL KNOW

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2024-12-09
Est. Completion 2026-01-31
Phase NA

What the Registry Record Tells You About NCT05143255

The ClinicalTrials.gov registry entry for NCT05143255 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (97% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which KNOW is the first listed.

NCT05143255 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05143255 about?

NCT05143255 is a clinical study titled "Developing a Communication Intervention for People With Memory Challenges and Their Care Partners". The proposed research is consistent with broader public health goals focused on improving communication regarding end-of-life care and the Centers for Medicare and Medicaid Services' (CMS) call for increased patient engagement in advance care planning (ACP) as part of standard care. The proposed stu...

What is the current status of trial NCT05143255?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-12-09. Estimated completion is 2026-01-31.

What conditions does trial NCT05143255 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia.

What interventions are being tested in trial NCT05143255?

The interventions under investigation include: KNOW (BEHAVIORAL).

Who is sponsoring clinical trial NCT05143255?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05143255 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.